Open AccessDisparity in public funding of systemic therapy for metastatic renal cell carcinoma within Canada
Author(s) -
Emily Jackson,
Sébastien J. Hotte
Publication year - 2022
Publication title -
canadian urological association journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.477
H-Index - 38
eISSN - 1920-1214
pISSN - 1911-6470
DOI - 10.5489/cuaj.7846
Subject(s) - pazopanib , medicine , sunitinib , formulary , temsirolimus , ipilimumab , cabozantinib , family medicine , lenvatinib , sorafenib , expanded access , renal cell carcinoma , cancer , oncology , apoptosis , biochemistry , chemistry , protein kinase b , immunotherapy , hepatocellular carcinoma , discovery and development of mtor inhibitors
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom